In a patient with chronic cough and no asthma who is taking propranolol (Inderal XL 80 mg), what is the appropriate management?

Propranolol is likely causing or exacerbating this patient's chronic cough and should be discontinued immediately.

In a patient with chronic cough on propranolol (Inderal XL 80 mg) without asthma, the beta-blocker is a probable culprit and must be stopped. Beta-blockers, particularly non-selective agents like propranolol, can induce bronchospasm and cough even in patients without a history of asthma 1, 2, 3.

Why Propranolol Must Be Stopped

The evidence is clear that propranolol causes respiratory complications:

• Propranolol can cause life-threatening bronchospasm in patients without asthma history 1. Three patients with no asthma developed severe bronchospasm on propranolol, with one experiencing respiratory arrest.

• Non-selective beta-blockers worsen airway function in chronic lung conditions 2, 3. Studies show significant increases in airway resistance and decreased flow rates within 1-4 hours of propranolol administration.

• The drug label explicitly warns about bronchospasm risk, though it doesn't specifically list cough as a common adverse effect 4.

Systematic Approach After Stopping Propranolol

Once propranolol is discontinued, follow this algorithmic evaluation:

Step 1: Immediate Actions

• Stop propranolol and replace with an alternative antihypertensive (avoid all beta-blockers) 5, 6
• Observe for cough resolution over 1-4 weeks

Step 2: If Cough Persists - Rule Out Common Causes

Chronic cough guidelines mandate systematic evaluation for the "big three" causes 7, 5:

1. Upper Airway Cough Syndrome (UACS) - formerly postnasal drip

   • Trial first-generation antihistamine/decongestant 5, 6
   • If upper airway symptoms present, add topical nasal corticosteroid 8

2. Cough-Variant Asthma or Eosinophilic Bronchitis

   • Perform bronchial provocation testing if spirometry normal 8
   • If testing unavailable: empiric 2-week oral corticosteroid trial 8
   • No response to steroids effectively rules out eosinophilic inflammation 8

3. Gastroesophageal Reflux Disease (GERD)

   • Intensive acid suppression with PPI + alginates for minimum 3 months 8
   • GERD-related cough often occurs without GI symptoms 8

Step 3: Sequential and Additive Treatment

Treat in sequential steps, adding therapies cumulatively since multiple causes often coexist 5, 6, 5. Don't stop one treatment when starting another.

Step 4: If Unexplained After Full Workup

If cough persists despite negative testing and adequate therapeutic trials 7:

1. Multimodality speech pathology therapy (Grade 2C recommendation) 7

2. Gabapentin trial if quality of life severely impacted 7:

   • Start 300 mg once daily
   • Escalate as tolerated to maximum 1,800 mg/day in divided doses
   • Discuss risks/benefits upfront
   • Reassess risk-benefit at 6 months before continuing

3. Do NOT prescribe:

   • Inhaled corticosteroids if bronchial hyperresponsiveness and eosinophilia testing negative 7
   • PPIs if GERD workup negative 7

Critical Pitfalls to Avoid

• Never continue any beta-blocker in a patient with troublesome cough 8. Even "selective" beta-1 blockers like atenolol and bisoprolol cause airway problems 3, 9.

• Don't rely on patient history alone to rule in/out asthma - objective testing required 5, 6

• Don't assume single cause - up to 62% have multiple contributing factors 5

• Smoking cessation is mandatory if applicable - 90% resolution rate 10

The most recent guideline evidence (2016 CHEST) emphasizes that propranolol-related cough should resolve within weeks of discontinuation 7. If it doesn't, systematic protocol-based evaluation is essential, as "unexplained" cough should only be diagnosed after thorough specialist assessment 7, 8.